Last week, Sana Biotechnology, a once-mysterious and still-buzzy biotech startup, released clinical trial results showing that it had managed to implant insulin-producing cells in the arm muscle ...
Abdul Khan stabbed father-of-two Bodhan Vandzhura 39 times in the street following a “significant misdiagnosis” that allowed him to be released from a secure ward two months earlier.
Penn State linebacker Abdul Carter is heading into the 2025 NFL Draft as one of the most highly-touted prospects in this year's class. Carter just finished his third season as a leader of the ...
Hours after Penn State's 27-24 loss to Notre Dame in the College Football Playoff semifinal, star pass-rusher Abdul Carter declared for the 2025 NFL draft. Per ESPN's Adam Schefter, Carter has ...
Penn State All-America defensive end Abdul Carter is entering the NFL draft, where he is expected to go early in the first round, his agent, Drew Rosenhaus, told ESPN's Adam Schefter on Friday.
Despite playing through a shoulder injury suffered in Penn State's Fiesta Bowl win over Boise State, Abdul Carter made his presence known in Thursday night's College Football Playoff loss to Notre ...
"We anticipate Abdul playing. He's doing everything he possibly can to play. His approach has been awesome. He's lived in the training room. But it'll be a game-time decision, and we'll see ...
Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with type 1 diabetes, sending the company’s share price up by about 200%.
Sana Biotechnology (SANA) and eBay (EBAY) are two of the stocks rallying this morning despite the market's losses. Sana is soaring nearly 250%, while eBay is climbing a much more modest 12%.
Sana’s HIP technology is designed to overcome the immunologic rejection of allogeneic cells. In type 1 diabetes, it also evades the autoimmune rejection of pancreatic beta cells. UP421 cells ...
Sana Biotechnology, Inc SEATTLE, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today ...